Project Grant R01DE035840
- Federal Grant Award Summary Oregon Health & Science University received $597,807 in Project Grant funding from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) to establish a novel 13C-labeled oral bacterial metabolite reference library for studying dental caries. The award, effective August 19, 2025, with completion targeted for July 31, 2027, supports the development of a comprehensive metabolite...
- Federal Grant Award Summary Oregon Health & Science University received $121,667 in Project Grant funding from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded April 1, 2026, with completion anticipated March 31, 2028. The award funds the development and validation of novel granular hydrogel platforms for theranostic (combined therapeutic and diagnostic) management of periodontitis, an oral...
- Award Summary Oregon Health & Science University (OHSU) received a $429,000 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective June 10, 2025, with completion targeted for May 31, 2027. The award supports research to overcome the genetic intractability barrier that has historically limited scientific understanding of the Prevotella genus, which comprises abundant and diverse oral...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded Oregon State University a $422,665 Project Grant on June 17, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop an integrated dental plaque bioanalytical platform for point-of-care diagnostics of oral diseases. The research addresses the significant financial burden of dental caries by creating a quantitative electrochemical biosensing platform capable...
- Federal Grant Award Summary Oregon Health & Science University received a $1.39 million Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective July 1, 2025, through March 31, 2030. The award supports the development and validation of an innovative organ-on-a-chip model designed to elucidate the mechanisms of oral squamous cell carcinoma (OSCC) invasion into bone tissue. The research...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $620,000 to the University of Minnesota's Office of Sponsored Projects Administration under the Oral Diseases and Disorders Research program (CFDA 93.121) on June 1, 2025, for a two-year project period concluding May 31, 2027. This Project Grant supports research to identify and characterize natural products synthesized by Streptococcus mutans that demonstrate antimicrobial and...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $540,629 to the University of Massachusetts Lowell on August 15, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to support research investigating human oral host-pathogen interactions and dysbiosis modulation. The project, scheduled for completion by August 14, 2027, focuses on developing and validating an immunocompetent three-dimensional (3D) in vitro model...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $426,250 to the University of Kansas Medical Center Research Institute, Inc. on August 14, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to support basic research on pathogenic mechanisms in Streptococcus sanguinis. The two-year project, concluding August 13, 2027, will characterize two endopeptidases (SEPM homologs) encoded by this oral bacterium that can...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded the University of Florida a Project Grant totaling $419,375 under the Oral Diseases and Disorders Research program (CFDA 93.121) on January 16, 2026, with a completion date of January 15, 2028. This research initiative investigates the roles of extracellular pyruvate in regulating Streptococcus mutans physiology and stress resistance, with particular focus on the LRGAB membrane protein...
- Federal Grant Award Summary Oregon Health & Science University received a $1.24 million Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded June 13, 2025, with completion targeted for June 12, 2027. The project focuses on developing short-wave infrared (SWIR) fluorophores to enhance intraoperative visualization of buried nerves during head and neck cancer surgery. Current...
Oregon Health & Science University (OHSU) received a $634,041 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective May 1, 2026 through April 30, 2031. The award supports research to elucidate the structural and mechanistic properties of the RNA degradosome in Streptococcus mutans, the bacterium primarily associated with dental caries risk. The research employs an integrated multidisciplinary approach utilizing genetics, advanced mass spectrometry, next-generation sequencing, cryo-electron microscopy, and innovative interspecies biofilm models to map degradosome targeting specificity and characterize moonlighting protein interactions that regulate global posttranscriptional gene expression. The project's core research deliverables include: (1) comprehensive characterization of moonlighting protein interactions and transcript targeting mechanisms by the degradosome; (2) development of mechanistic structural and biochemical models of degradosome-substrate complexes; and (3) assessment of the therapeutic potential of inhibiting protein moonlighting interactions as a strategy for strain-specific S. mutans depletion in the oral cavity. These research outputs are designed to advance fundamental understanding of bacterial genetic regulation while identifying novel therapeutic targets for combating the global disease burden associated with dental caries.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $634.0k | 4/30/26 |